v3.26.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2026
Dec. 31, 2025
Current assets    
Cash and cash equivalents $ 15,421,170 $ 16,578,857
Accounts receivable, net 12,572,651 11,998,075
Inventory, net 3,459,921 3,948,748
Prepaid and other assets 741,733 948,620
Current assets related to discontinued operations (Note 3) 5,203 67,863
Total current assets 32,200,678 33,542,163
Long-term assets    
Intangible assets, net 17,277,013 18,640,673
Goodwill 3,601,781 3,601,781
Investment in equity securities 13,730,703 14,626,858
Right of use assets – operating leases 1,909,278 2,075,634
Property and equipment, net 426,934 456,962
Total long-term assets 36,945,709 39,401,908
Total assets 69,146,387 72,944,071
Current liabilities    
Accounts payable 1,401,443 2,338,761
Accrued bonuses and commissions 6,801,395 11,781,435
Accrued royalties and expenses 3,562,415 2,684,626
Earnout liabilities – current 235,001
Operating lease liabilities – current 383,153 353,229
Current liabilities related to discontinued operations (Note 3) 345,585 1,233,478
Total current liabilities 12,493,991 18,626,530
Long-term liabilities    
Long-term debt 46,477,087 45,970,937
Operating lease liabilities – long-term 1,669,529 1,868,703
Other long-term liabilities 571,320 548,125
Total long-term liabilities 48,717,936 48,387,765
Total liabilities 61,211,927 67,014,295
Commitments and contingencies (Note 9)
Shareholders’ equity    
Common Stock: $0.001 par value, 20,000,000 shares authorized; 9,193,394 issued and outstanding as of June 30, 2026 and 8,946,913 issued and outstanding as of December 31, 2025 9,194 8,948
Additional paid-in capital 82,826,049 81,232,536
Accumulated deficit (74,891,763) (75,303,042)
Total Sanara MedTech shareholders’ equity 7,943,480 5,938,442
Equity attributable to noncontrolling interest (9,020) (8,666)
Total shareholders’ equity 7,934,460 5,929,776
Total liabilities and shareholders’ equity $ 69,146,387 $ 72,944,071